Soulen – Who Should Get PRRT Weighing Cumulative Toxicity Key to PRRT Treatment
Michael C. Soulen, MD of the University of Pennsylvania answers the question “Who Should Get PRRT?”. He summarizes that you must weigh cumulative toxicity which may be key to PRRT (Peptide Receptor Radionuclide Therapy) treatment from ASCO GI 2018.
Advertisement